<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pregnancy loss (miscarriage): Ultrasound diagnosis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pregnancy loss (miscarriage): Ultrasound diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Pregnancy loss (miscarriage): Ultrasound diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sarah Prager, MD, MAS</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elizabeth Micks, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Vanessa K Dalton, MD, MPH</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert L Barbieri, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Courtney A Schreiber, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Liina Poder, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen Eckler, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 01, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1097364758"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Pregnancy loss, also referred to as miscarriage or spontaneous abortion, is generally defined as a nonviable intrauterine pregnancy up to 20 weeks of gestation. Early pregnancy loss, which occurs in the first trimester (ie, up to 12+6 weeks gestation), is the most common type. The diagnosis of pregnancy loss is generally confirmed with transvaginal ultrasound evaluation.</p><p>This topic will review the clinical criteria and when they may be applied for making an ultrasound diagnosis of pregnancy loss. Related content on risk factors and etiology, clinical presentation, treatment options, and management protocols is presented separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5439.html" rel="external">"Pregnancy loss (miscarriage): Terminology, risk factors, and etiology"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5442.html" rel="external">"Pregnancy loss (miscarriage): Clinical presentations, diagnosis, and initial evaluation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/130834.html" rel="external">"Pregnancy loss (miscarriage): Counseling and comparison of treatment options and discussion of related care"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/128965.html" rel="external">"Pregnancy loss (miscarriage): Description of management techniques"</a>.)</p><p></p><p>Content specific to individuals with recurrent pregnancy loss is discussed elsewhere.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5437.html" rel="external">"Recurrent pregnancy loss: Definition and etiology"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5436.html" rel="external">"Recurrent pregnancy loss: Evaluation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5444.html" rel="external">"Recurrent pregnancy loss: Management"</a>.)</p><p></p><p>In this topic, we will use the term "patient" to describe genetic females and use “woman/en” as used in the included studies. However, we encourage the reader to consider the specific counseling needs of transgender and gender nonbinary individuals.</p><p class="headingAnchor" id="H3947550718"><span class="h1">ROLE OF ULTRASOUND</span><span class="headingEndMark"> — </span>When available, ultrasound, particularly transvaginal ultrasound, is generally performed in all pregnant individuals with signs or symptoms suggestive of pregnancy loss to confirm the presence or absence of normal, or abnormal, intrauterine gestation and exclude findings suggestive of ectopic pregnancy.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5442.html" rel="external">"Pregnancy loss (miscarriage): Clinical presentations, diagnosis, and initial evaluation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5487.html" rel="external">"Ectopic pregnancy: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H1216551382"><span class="h2">Choice of imaging route</span><span class="headingEndMark"> — </span>In general, pelvic ultrasound starts with transabdominal evaluation for a general overview and then includes transvaginal imaging as needed. For early pregnancy, transvaginal imaging is performed if transabdominal evaluation is technically inadequate or inconclusive  (<a class="graphic graphic_diagnosticimage graphicRef65928 graphicRef56290 graphicRef65128" href="/z/d/graphic/65928.html" rel="external">image 1A-C</a>) [<a href="#rid1">1</a>]. </p><p>Transabdominal ultrasound can only be used in instances where the gestational sac is high above the cervix (for example, in fibroid uterus), and transperineal ultrasound may also be utilized, albeit infrequently [<a href="#rid1">1</a>]. The choice of transducer route and frequency is based on the clinical scenario, patient habitus, likely gestational age of pregnancy (if known), and availability of equipment. (See  <a class="medical medical_review" href="/z/d/html/5410.html" rel="external">"Ultrasonography of pregnancy of unknown location", section on 'Transabdominal versus transvaginal'</a>.)</p><p class="headingAnchor" id="H1218161914"><span class="h2">Ultrasound findings in first trimester</span><span class="headingEndMark"> — </span>When using transvaginal ultrasound, gestational landmarks include identification of a gestational sac (4.5 to 5 weeks)  (<a class="graphic graphic_diagnosticimage graphicRef56290" href="/z/d/graphic/56290.html" rel="external">image 1B</a>), yolk sac (5 weeks)  (<a class="graphic graphic_diagnosticimage graphicRef65928 graphicRef65128" href="/z/d/graphic/65928.html" rel="external">image 1C</a>), cardiac activity (5.5 to 6 weeks)  (<a class="graphic graphic_movie graphicRef98064" href="/z/d/graphic/98064.html" rel="external">movie 1</a>), and crown-rump length (CRL; 6 weeks)  (<a class="graphic graphic_diagnosticimage graphicRef94938" href="/z/d/graphic/94938.html" rel="external">image 2</a> and <a class="graphic graphic_table graphicRef83304" href="/z/d/graphic/83304.html" rel="external">table 1</a>). Measurement of the CRL provides the most accurate assessment of gestational age, but mean sac diameter can also be used  (<a class="graphic graphic_table graphicRef83304" href="/z/d/graphic/83304.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef94449" href="/z/d/graphic/94449.html" rel="external">table 2</a>) [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/z/d/html/5391.html" rel="external">"Prenatal assessment of gestational age, date of delivery, and fetal weight", section on 'First-trimester gestational age assessment'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Crown-rump length</strong> – An international standard for ultrasound dating of pregnancy based on CRL measurement was developed by the International Fetal and Newborn Growth Consortium for the 21<sup>st</sup> Century and is available online at <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fintergrowth21.tghn.org%2Farticles%2Finternational-standards-early-fetal-size-and-pregnancy-dating-based-ultrasound-measurement-crown-rump-length-first-trimester%2F&amp;token=nPqrAftU%2FbuXOZcTcEEsJ92yenZJlStAfpEjQr6zHJSDQ7DNEQaBQMyIc7%2FrmQzBDA%2FMpz%2BJw6Ox4DdCbWmNQTkHKV5q%2FftxfKmmIFxP5YlvLqIT%2FjvyIGDZ7K6Q5zlAZXNKGoLVqaQkFzAmqC8w3L4wdzW%2FfLezLuXZpxGTDXw%3D&amp;TOPIC_ID=130879" target="_blank">INTERGROWTH-21</a> [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/z/d/html/5391.html" rel="external">"Prenatal assessment of gestational age, date of delivery, and fetal weight", section on 'First-trimester gestational age assessment'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ultrasound findings by trimester</strong> – The specific components of late first- versus second- and third-trimester examinations are described in detail in the American Institute of Ultrasound in Medicine-American College of Radiology-American College of Obstetricians and Gynecologists-Society for Maternal-Fetal Medicine-Society of Radiologists in Ultrasound (AIUM-ACR-ACOG-SMFM-SRU) Practice Parameter for the Performance of Standard Diagnostic Obstetric Ultrasound Examinations, which is beyond the scope of this topic [<a href="#rid3">3</a>]. (See  <a class="medical medical_review" href="/z/d/html/5391.html" rel="external">"Prenatal assessment of gestational age, date of delivery, and fetal weight", section on 'Second- and third-trimester gestational age assessment'</a>.)</p><p></p><p class="headingAnchor" id="H3793620365"><span class="h2">Timing of ultrasound from last menstrual period</span><span class="headingEndMark"> — </span>The timing of initial ultrasound in asymptomatic pregnant individuals varies. We advise that a pelvic ultrasound be deferred until seven weeks of gestation from the last menstrual period to avoid unnecessary evaluations for pregnancy of unknown location or embryos with slow or absent cardiac activity. An initial ultrasound for a patient at seven to eight weeks of gestation is more likely to identify the presence of embryonic cardiac activity and thus avoid the need for a follow-up ultrasound. Individuals with risk factors for pregnancy loss may undergo ultrasound at the initial prenatal visit, while for others the first ultrasound may occur at the time of first-trimester aneuploidy screening or at the time of second-trimester fetal anatomy assessment. (See  <a class="medical medical_review" href="/z/d/html/5410.html" rel="external">"Ultrasonography of pregnancy of unknown location"</a>.)</p><p class="headingAnchor" id="H1174230308"><span class="h1">ULTRASOUND DIAGNOSIS OF PREGNANCY LOSS</span><span class="headingEndMark"> — </span>Pregnancy loss can be diagnosed with both serial and single ultrasound studies; the selection depends on the imaging findings  (<a class="graphic graphic_table graphicRef139961" href="/z/d/graphic/139961.html" rel="external">table 3</a>) and the patient's preferences, including tolerance for a false-positive diagnosis  (<a class="graphic graphic_algorithm graphicRef140173" href="/z/d/graphic/140173.html" rel="external">algorithm 1</a>).</p><p class="headingAnchor" id="H1012719417"><span class="h2">Serial ultrasound studies</span><span class="headingEndMark"> — </span>Once an intrauterine pregnancy is identified on ultrasound, pregnancy loss is diagnosed if any subsequent ultrasound (performed routinely or for symptoms) shows no or abnormal intrauterine pregnancy or loss of previously seen cardiac activity [<a href="#rid4">4</a>]. Ultrasound is further used to confirm appropriate intrauterine location of pregnancy (to exclude cesarean scar, cervical, or interstitial implantation), absence of cardiac activity, and approximate gestational age at which development stopped. The gestational age of the pregnancy by ultrasound criteria may differ from the gestational age by last menstrual period. (See <a class="local">'Additional diagnostic challenges'</a> below.)</p><p class="headingAnchor" id="H3180450891"><span class="h2">Single ultrasound diagnostic criteria</span></p><p class="headingAnchor" id="H477420948"><span class="h3">Our approach</span><span class="headingEndMark"> — </span>Evidence-based guidelines exist for the sonographic diagnosis of pregnancy loss  (<a class="graphic graphic_table graphicRef139961" href="/z/d/graphic/139961.html" rel="external">table 3</a>) [<a href="#rid4">4-9</a>]. In our practice, we use this information and further consider the preferences of the patient in applying the diagnostic criteria  (<a class="graphic graphic_algorithm graphicRef140173" href="/z/d/graphic/140173.html" rel="external">algorithm 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Highest diagnostic certainty</strong> – For patients who desire more time to confirm the diagnosis and/or desire the highest diagnostic certainty, we apply the Society of Radiologists in Ultrasound (SRU) criteria for early pregnancy loss  (<a class="graphic graphic_table graphicRef139961" href="/z/d/graphic/139961.html" rel="external">table 3</a> and <a class="graphic graphic_algorithm graphicRef140173" href="/z/d/graphic/140173.html" rel="external">algorithm 1</a>) [<a href="#rid5">5</a>]. Criteria include a mean gestational sac diameter ≥25 mm (without a yolk sac or embryo  (<a class="graphic graphic_diagnosticimage graphicRef130909 graphicRef77246" href="/z/d/graphic/130909.html" rel="external">image 3A-B</a>)) or an embryo with crown-rump length (CRL) ≥7 mm and without cardiac activity  (<a class="graphic graphic_diagnosticimage graphicRef130903" href="/z/d/graphic/130903.html" rel="external">image 4</a>)) as visualized with transvaginal ultrasound [<a href="#rid4">4,5</a>]. This approach is endorsed by the SRU as well as several academic societies and government agencies globally  (<a class="graphic graphic_table graphicRef139961" href="/z/d/graphic/139961.html" rel="external">table 3</a>) [<a href="#rid4">4-9</a>]. (See <a class="local">'Available diagnostic criteria'</a> below.)</p><p></p><p class="bulletIndent1">With this approach, the specificity and positive predictive values are essentially 100 percent [<a href="#rid5">5</a>] and both intra- and interobserver variability has been considered, which is important given the wide range of transvaginal ultrasound training and skill [<a href="#rid10">10</a>]. These criteria may be particularly helpful for individuals who wish to wait longer to confirm pregnancy loss and/or wish the lowest risk of false diagnosis, but this may result in treatment delay for some individuals if applied universally.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reasonable diagnostic certainty</strong> – For clinicians who are highly skilled at transvaginal sonography <strong>and</strong> patients who desire expedited treatment for pregnancy loss, it is reasonable to apply the criteria that include a mean gestational sac diameter ≥21 mm or a CRL of ≥6 mm without cardiac activity (as visualized with transvaginal ultrasound) to confirm pregnancy loss  (<a class="graphic graphic_algorithm graphicRef140173" href="/z/d/graphic/140173.html" rel="external">algorithm 1</a>) [<a href="#rid11">11</a>]. These criteria are based on data from an observational study, are not endorsed in society guidelines, and are not to be used by clinicians unexperienced in performing transvaginal ultrasonography  (<a class="graphic graphic_table graphicRef130912" href="/z/d/graphic/130912.html" rel="external">table 4</a>) [<a href="#rid5">5,11</a>]. (See <a class="local">'Available diagnostic criteria'</a> below.)</p><p></p><p class="bulletIndent1">In a setting of high-quality transvaginal ultrasonography, this approach allows the patient to efficiently proceed with treatment with high diagnostic certainty (0 percent false-positive rate in some studies). However, as imaging studies can be limited both by the quality of the machine used and the clinician's interpretation, these variables should be considered when managing patients whose pregnancies are at the threshold of the measurement cut points and placed into the context of the patient's needs. Patients should understand that there may be a slight risk of interrupting normal progress.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rationale</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Rationale for highest diagnostic certainty criteria</strong> – The higher ultrasound thresholds for diagnosing early pregnancy loss address the following issues:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Variable quality of sonography</strong> – Much of the research in diagnosis of early pregnancy loss relies on data from expert sonographers and radiologists [<a href="#rid5">5</a>]. Variations in ultrasound equipment and skill or training of the provider will affect measurements. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Impact of patient factors </strong>– Patient factors such as obesity, uterine fibroids, and uterine position can make visualization of the pregnancy more difficult. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Rationale for reasonable diagnostic certainty</strong> – The authors' concern with only using the criteria set forth by the SRU is that interobserver reliability was already accounted for in the prior studies, which resulted in less conservative criteria [<a href="#rid4">4,5</a>] (see <a class="local">'Available diagnostic criteria'</a> below). </p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Importance of patient preferences and other clinical data</strong> – While clinicians never want to falsely diagnose a live pregnancy as a pregnancy loss, we similarly would never want a patient to have delayed management of a pregnancy loss due to not meeting conservative ultrasonographic criteria. Additionally, sonographic imaging is only one element of diagnosing a miscarriage, and the overall clinical picture includes other data that might suggest a benefit from applying less conservative ultrasonographic criteria (eg, plateau or fall in human chorionic gonadotropin levels). (See  <a class="medical medical_review" href="/z/d/html/440.html" rel="external">"Clinical manifestations and diagnosis of early pregnancy", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Authors' interpretation of the data</strong> – Based on the observational data, mean gestational sac diameter ≥21 mm <strong>or</strong> CRL ≥6 mm could be reasonably used as cutoffs for diagnosing pregnancy loss with a single ultrasound and without the need for a follow-up study or evaluation  (<a class="graphic graphic_table graphicRef130912" href="/z/d/graphic/130912.html" rel="external">table 4</a>). The rationale for rounding up from 5.3 to 6 mm is the limited submillimeter precision of ultrasound measurements in this setting, coupled with the known false-positive rate at 5 mm with absent cardiac activity [<a href="#rid10">10</a>]. While the authors of the study advise a mean gestational sac diameter cutoff of ≥25 mm and a CRL cutoff of ≥7 to conservatively allow for interobserver variability and minimize the risk of a false-positive diagnosis of miscarriage, we believe these cutoffs are overly cautious given the false-positive rates of 0 and use mean gestational sac diameter ≥21 mm and CRL ≥6 mm in our practices.</p><p></p><p class="headingAnchor" id="H266282381"><span class="h3">Points of debate</span><span class="headingEndMark"> — </span>Criteria for diagnosing pregnancy loss with a single ultrasound examination are a matter of debate and interpretation of available data because the criteria are influenced by the dataset used, clinical context, expertise of the sonographer, quality of the ultrasound machine, and the patient's need for diagnostic certainty.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Concern for false-positive test result</strong> – One concern is that a false-positive test result (ie, a live pregnancy is incorrectly diagnosed as a pregnancy loss) could inadvertently result in termination of a desired, healthy pregnancy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical context and patient-centered care</strong> – The entire clinical context must be taken into consideration when implementing the available guidelines. Clinical issues for consideration include the individual's "desire to continue the pregnancy, willingness to postpone intervention to achieve 100 percent certainty of pregnancy loss, and the potential consequences of waiting for intervention, including unwanted spontaneous passage of pregnancy tissue, the need for an unscheduled visit or procedure, and patient anxiety" [<a href="#rid4">4</a>]. Depending on a patient's desires and preferences, it is appropriate to diagnose and manage early pregnancy loss when the clinical context is highly suggestive of loss but does not meet the strictest diagnostic criteria.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Impact of sonographer, anatomic approach, and equipment </strong>– When using single ultrasound criteria to evaluate for pregnancy loss, baseline considerations include use of transvaginal or transabdominal approach, skill of sonographer, and quality of equipment. Additionally, M-mode is advised for evaluation of embryonic cardiac activity rather than pulsed or color Doppler to minimize any theoretical risks of thermal damage to the embryo.</p><p></p><p class="bulletIndent1">In cases where the sac or embryonic pole measurement is at the diagnostic boundary, the experience and skill of the sonographer become extremely important because interobserver variability has been described [<a href="#rid10">10</a>]. In settings of diagnostic uncertainty, repeat imaging may be warranted if the patient desires additional confirmatory data.</p><p></p><p class="headingAnchor" id="H2611530345"><span class="h3">Available diagnostic criteria</span><span class="headingEndMark"> — </span>The suggested ultrasound criteria below for diagnosing nonviable pregnancy are based on studies performed starting in the early 1990s through the early 2000s  (<a class="graphic graphic_table graphicRef130912" href="/z/d/graphic/130912.html" rel="external">table 4</a>). As these studies were performed, ultrasound technology and experience continued to evolve, which may account, in part, for their differences.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Observational study data </strong>– A 2011 observational cross-sectional study attempted to define the false-positive rates (FPRs) for different CRLs and mean gestational sac diameters by ultrasound assessment [<a href="#rid11">11</a>]. Data were collected prospectively for 1060 patients with a diagnosis of intrauterine pregnancy of uncertain viability. For the 585 individuals with nonviable pregnancies, the authors reported the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In the setting of an embryo with absent heartbeat, the FPR was 8.3 percent with CRLs of 4 and 5 mm, but 0 for a CRL ≥5.3 mm.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For mean gestational sac diameter, in the absence of both embryo and yolk sac, the FPRs for correctly diagnosing nonviable pregnancy were 4.4, 0.5, and 0 percent for cutoffs of 16, 20, and ≥21 mm, respectively.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For mean gestational sac diameter with a visible yolk sack but absent embryo, FPRs of 2.6, 0.4, and 0 percent were reported for mean gestational sac diameter cutoffs of 16, 20, and ≥21 mm, respectively.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>SRU criteria</strong> – In 2013, the SRU reviewed the available data and proposed even more stringent criteria than that which resulted in a 0 percent FPR in the prior studies  (<a class="graphic graphic_table graphicRef130912" href="/z/d/graphic/130912.html" rel="external">table 4</a>) [<a href="#rid5">5,11</a>]. Their stated goal was to achieve 100 percent specificity and positive predictive value (ie, no chance of incorrectly diagnosing a live pregnancy as nonviable), citing concerns about the potential for intra- and interobserver variability and/or differing levels of provider skill or ultrasound precision and their potential to lead to a false-positive diagnosis of pregnancy loss in the setting of a pregnancy that was actually alive [<a href="#rid4">4,5</a>].</p><p></p><p class="bulletIndent1">The 2012 SRU Multispecialty Panel on Early First Trimester Diagnosis of Miscarriage and Exclusion of a Viable Intrauterine Pregnancy guidelines proposed the following ultrasound criteria to diagnose pregnancy loss [<a href="#rid5">5</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A gestational sac ≥25 mm in mean diameter that does not contain a yolk sac or embryo  (<a class="graphic graphic_diagnosticimage graphicRef130909 graphicRef77246" href="/z/d/graphic/130909.html" rel="external">image 3A-B</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>An embryo with a CRL ≥7 mm that does not have cardiac activity.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Absence of an embryo with a heartbeat in ≥2 weeks from a prior ultrasound demonstrating a gestational sac without a yolk sac.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>After a pelvic ultrasound showed a gestational sac with a yolk sac, absence of an embryo with a heartbeat in ≥11 days.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Historical data </strong>– Initial studies published in the early 1990s attempted to determine the embryonic size at which cardiac activity was always present in normal pregnancy. After evaluating 398 transvaginal ultrasound studies performed in early pregnancy, the authors concluded that absence of cardiac activity in a visualized embryo usually signified embryonic demise [<a href="#rid12">12</a>]. However, in the absence of cardiac activity, definitive diagnosis of pregnancy demise was to be avoided if the CRL was less than 5 mm because two embryos (2 and 4 mm) initially had absent cardiac activity but progressed to normal outcome. The second study prospectively evaluated 309 consecutive early pregnancies, of which 175 were normal, with vaginal and abdominal ultrasound [<a href="#rid13">13</a>]. Using vaginal ultrasound, one-third of embryos with CRL &lt;5 mm did not have visualized cardiac activity compared with 100 percent of embryos ≥5 mm. Additionally, an empty gestational sac of &lt;12 mm average diameter was not able to predict nonviable pregnancy.</p><p></p><p class="bulletIndent1">Based on these studies, initial criteria for nonviable early pregnancy included  (<a class="graphic graphic_table graphicRef130912" href="/z/d/graphic/130912.html" rel="external">table 4</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>CRL of 5 mm without cardiac activity.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Empty gestational sac measuring 16 mm in mean gestational sac diameter.</p><p></p><p class="headingAnchor" id="H3314737974"><span class="h2">Additional diagnostic challenges</span><span class="headingEndMark"> — </span>Scenarios that can make the assessment of early pregnancy more challenging include discrepancy in the gestational age based on last menstrual period or date of conception versus ultrasound, presence of multiple gestations, and inability to identify an intrauterine pregnancy with the resultant diagnosis of pregnancy of unknown location.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gestational age discrepancy</strong> – In patients for whom the gestational age of the pregnancy measured on ultrasound is substantially smaller than the expected gestational age based on last menstrual period or conception date, providers must discuss the possibility that ovulation occurred later than expected and discuss the diagnostic criteria needed to confirm pregnancy loss. The gestational age can be determined using mean sac diameter  (<a class="graphic graphic_table graphicRef94449" href="/z/d/graphic/94449.html" rel="external">table 2</a>). (See  <a class="medical medical_review" href="/z/d/html/5391.html" rel="external">"Prenatal assessment of gestational age, date of delivery, and fetal weight"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Multiple gestation</strong> – Occasionally, ultrasound will visualize a multiple gestation with one gestational sac showing reduced growth or lack of yolk sac or embryonic pole. In these cases, pregnancy loss is not diagnosed unless both gestational sacs meet the above criteria. (See  <a class="medical medical_review" href="/z/d/html/6821.html" rel="external">"Twin pregnancy: Overview"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pregnancy of unknown location</strong> – Individuals with a positive pregnancy test but no intrauterine pregnancy seen on ultrasound are assessed as having a pregnancy of unknown location and followed carefully with repeat imaging and possibly serial serum human chorionic gonadotropin levels until the location can be determined. Alternatively, diagnostic uterine aspiration can be performed to expedite the location diagnosis when preserving a possible intrauterine or extrauterine pregnancy is not the priority [<a href="#rid14">14</a>]. Differential diagnosis includes an early intrauterine pregnancy, an ectopic pregnancy, a miscarriage, or a molar pregnancy. (See  <a class="medical medical_review" href="/z/d/html/5410.html" rel="external">"Ultrasonography of pregnancy of unknown location"</a>.)</p><p></p><p class="headingAnchor" id="H4197482434"><span class="h2">Other ultrasound findings in early pregnancy</span><span class="headingEndMark"> — </span>Separate from the criteria above, additional ultrasound findings may be suggestive of pregnancy outcome.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Suggestive of non-viable pregnancy</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Expanded or empty amnion </strong>–<strong> </strong>The presence of an expanded amnion greater than expected for the size of the embryo or an empty amnion can confirm pregnancy loss  (<a class="graphic graphic_diagnosticimage graphicRef130904" href="/z/d/graphic/130904.html" rel="external">image 5</a> and <a class="graphic graphic_diagnosticimage graphicRef130906" href="/z/d/graphic/130906.html" rel="external">image 6</a>). With appropriate ultrasound training and experience, these signs are very helpful since they allow for earlier diagnosis of a nonviable pregnancy [<a href="#rid15">15,16</a>]. The amnion is not typically seen as a separate structure, and is larger than the embryo until about eight to nine weeks; an amnion without an embryo or a small embryo with an amnion greater than anticipated size by gestational age is consistent with pregnancy loss.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Findings suggestive of poor outcome</strong> – While the findings below have been associated with poor pregnancy outcome, live pregnancy is not excluded with these findings and a follow-up ultrasound is indicated to further evaluate pregnancy viability. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Irregularly shaped gestational sac [<a href="#rid17">17,18</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Moderate or large subchorionic hematoma [<a href="#rid19">19,20</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Chorionic bump</strong> – A chorionic bump is a bulge or protrusion from the choriodecidual surface into the gestational sac [<a href="#rid21">21</a>]. This finding likely represents trapped blood as serial ultrasounds in one study showed changes similar to that of a hematoma [<a href="#rid22">22</a>]. A chorionic bump occurs in less than 1 percent of pregnancies, is not diagnostic of pregnancy loss, but can be associated with increased risk of loss (although studies vary) [<a href="#rid22">22-25</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Findings consistent with live pregnancy</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Gestational sac with yolk sac only</strong> – A gestational sac with a yolk sac does not have an embryonic pole early in development  (<a class="graphic graphic_diagnosticimage graphicRef130910" href="/z/d/graphic/130910.html" rel="external">image 7</a>). In the presence of symptoms (vaginal bleeding, pain), a repeat ultrasound may be warranted in 7 to 10 days to confirm viability.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Normal pregnancy with amnion</strong> – In early pregnancy with normal development, the amnion expands well beyond the limits of the embryo itself after approximately eight weeks  (<a class="graphic graphic_diagnosticimage graphicRef130911" href="/z/d/graphic/130911.html" rel="external">image 8</a>).</p><p></p><p class="headingAnchor" id="H962774946"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/114412.html" rel="external">"Society guideline links: Pregnancy loss (spontaneous abortion)"</a>.)</p><p class="headingAnchor" id="H1003937131"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/15610.html" rel="external">"Patient education: Pregnancy loss (The Basics)"</a> and  <a class="medical medical_basics" href="/z/d/html/17047.html" rel="external">"Patient education: Bleeding in early pregnancy (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/z/d/html/6724.html" rel="external">"Patient education: Pregnancy loss (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H3145608468"><span class="h1">PATIENT PERSPECTIVE TOPIC</span><span class="headingEndMark"> — </span>Patient perspectives are provided for selected disorders to help clinicians better understand the patient experience and patient concerns. These narratives may offer insights into patient values and preferences not included in other UpToDate topics. (See  <a class="medical medical_review" href="/z/d/html/132376.html" rel="external">"Patient perspective: Pregnancy loss"</a>.)</p><p class="headingAnchor" id="H689802616"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Role of ultrasound</strong> – When available, transabdominal and transvaginal ultrasound are generally performed in all pregnant individuals with signs or symptoms suggestive of pregnancy loss to confirm the presence or absence of normal, or abnormal, intrauterine gestation and exclude findings suggestive of ectopic pregnancy. (See <a class="local">'Role of ultrasound'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Imaging approach</strong> – Transabdominal, transvaginal, and transperineal ultrasound may all be used to assess pregnancy; the approach is determined by patient factors and available equipment. (See <a class="local">'Choice of imaging route'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pregnancy landmarks by gestational age</strong> – When using transvaginal ultrasound, gestational landmarks include identification of a gestational sac (4.5 to 5 weeks)  (<a class="graphic graphic_diagnosticimage graphicRef56290" href="/z/d/graphic/56290.html" rel="external">image 1B</a>), yolk sac (5 weeks)  (<a class="graphic graphic_diagnosticimage graphicRef65928 graphicRef65128" href="/z/d/graphic/65928.html" rel="external">image 1C</a>), cardiac activity (5.5 to 6 weeks)  (<a class="graphic graphic_movie graphicRef98064" href="/z/d/graphic/98064.html" rel="external">movie 1</a>), and crown-rump length (6 weeks)  (<a class="graphic graphic_diagnosticimage graphicRef94938" href="/z/d/graphic/94938.html" rel="external">image 2</a> and <a class="graphic graphic_table graphicRef83304" href="/z/d/graphic/83304.html" rel="external">table 1</a>). Measurement of the crown-rump length (CRL) provides the most accurate assessment of gestational age, but mean sac diameter can also be used  (<a class="graphic graphic_table graphicRef83304" href="/z/d/graphic/83304.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef94449" href="/z/d/graphic/94449.html" rel="external">table 2</a>) [<a href="#rid2">2</a>]. (See <a class="local">'Ultrasound findings in first trimester'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Serial ultrasound criteria</strong> – Once an intrauterine pregnancy is identified on ultrasound, pregnancy loss is diagnosed if any subsequent ultrasound (performed routinely or for symptoms) shows no or abnormal intrauterine pregnancy or loss of previously seen cardiac activity. (See <a class="local">'Serial ultrasound studies'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Single ultrasound criteria</strong> – Criteria for diagnosing pregnancy loss with a single ultrasound examination are a matter of debate and interpretation of available data because the criteria are influenced by the dataset used, clinical context, and the patient's need for diagnostic certainty. (See <a class="local">'Points of debate'</a> above and <a class="local">'Available diagnostic criteria'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Highest diagnostic certainty</strong> – For patients who desire the highest diagnostic certainty and/or more time to confirm the diagnosis , we apply the Society of Radiologists in Ultrasound (SRU) criteria that include a mean gestational sac diameter ≥25 mm (without a yolk sac or embryo) or an embryo with CRL ≥7 mm (without cardiac activity) as visualized with transvaginal ultrasound  (<a class="graphic graphic_algorithm graphicRef140173" href="/z/d/graphic/140173.html" rel="external">algorithm 1</a>). (See <a class="local">'Our approach'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Reasonable diagnostic certainty for expedited diagnosis</strong> – For patients who desire expedited treatment for pregnancy loss, it is reasonable to apply the criteria that include a mean gestational sac diameter ≥21 mm or a CRL ≥6 mm without cardiac activity, demonstrated with transvaginal ultrasound, to confirm pregnancy loss  (<a class="graphic graphic_algorithm graphicRef140173" href="/z/d/graphic/140173.html" rel="external">algorithm 1</a>). These criteria are for highly skilled sonographers only. This approach modifies the measurement thresholds given the context of the patient's needs. Patients should understand that there may be a slight risk of interrupting a normal pregnancy. (See <a class="local">'Our approach'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Additional challenges</strong> – Scenarios that can make the diagnosis of pregnancy loss more challenging include discrepancy in the gestational age based on last menstrual period or date of conception versus ultrasound, presence of multiple gestations, and pregnancy of unknown location. (See <a class="local">'Additional diagnostic challenges'</a> above.)</p><p></p><p class="headingAnchor" id="H3221539736"><span class="h1">ACKNOWLEDGMENTS</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Togas Tulandi, MD, MHCM, and Haya M Al-Fozan, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Committee on Practice Bulletins—Obstetrics and the American Institute of Ultrasound in Medicine. Practice Bulletin No. 175: Ultrasound in Pregnancy. Obstet Gynecol 2016; 128:e241. Reaffirmed 2022.</a></li><li><a class="nounderline abstract_t">Papageorghiou AT, Kennedy SH, Salomon LJ, et al. International standards for early fetal size and pregnancy dating based on ultrasound measurement of crown-rump length in the first trimester of pregnancy. Ultrasound Obstet Gynecol 2014; 44:641.</a></li><li><a class="nounderline abstract_t">AIUM-ACR-ACOG-SMFM-SRU Practice Parameter for the Performance of Standard Diagnostic Obstetric Ultrasound Examinations. J Ultrasound Med 2018; 37:E13. (available online at https://onlinelibrary.wiley.com/doi/10.1002/jum.14831)</a></li><li><a class="nounderline abstract_t">American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Gynecology. ACOG Practice Bulletin No. 200: Early Pregnancy Loss. Obstet Gynecol 2018; 132:e197. Reaffirmed 2021.</a></li><li><a class="nounderline abstract_t">Doubilet PM, Benson CB, Bourne T, et al. Diagnostic criteria for nonviable pregnancy early in the first trimester. N Engl J Med 2013; 369:1443.</a></li><li class="breakAll">Ultrasound Evaluation of First Trimester Complications of Pregnancy. SOGC Clinical Practice Guideline, Society of Obstetricians and Gynaecologists of Canada, October 2016. https://www.jogc.com/article/S1701-2163(16)39329-X/abstract?showall=true (Accessed on October 01, 2020).</li><li class="breakAll">Ectopic pregnancy and miscarriage: diagnosis and initial mangement. NICE guideline [NG126]. National Institute for Health Care and Excellence. April, 2019. https://www.nice.org.uk/guidance/ng126/chapter/Recommendations#expectant-management-2 (Accessed on May 26, 2021).</li><li class="breakAll">Pregnancy Loss. The Royal Australian and New Zealand College of Obstetricians and Gynecologists. March 2019. https://ranzcog.edu.au/RANZCOG_SITE/media/RANZCOG-MEDIA/Women%27s%20Health/Patient%20information/Pregnancy-Loss_2.pdf?ext=.pdf (Accessed on October 01, 2020).</li><li><a class="nounderline abstract_t">Coomarasamy A, Gallos ID, Papadopoulou A, et al. Sporadic miscarriage: evidence to provide effective care. Lancet 2021; 397:1668.</a></li><li><a class="nounderline abstract_t">Pexsters A, Luts J, Van Schoubroeck D, et al. Clinical implications of intra- and interobserver reproducibility of transvaginal sonographic measurement of gestational sac and crown-rump length at 6-9 weeks' gestation. Ultrasound Obstet Gynecol 2011; 38:510.</a></li><li><a class="nounderline abstract_t">Abdallah Y, Daemen A, Kirk E, et al. Limitations of current definitions of miscarriage using mean gestational sac diameter and crown-rump length measurements: a multicenter observational study. Ultrasound Obstet Gynecol 2011; 38:497.</a></li><li><a class="nounderline abstract_t">Brown DL, Emerson DS, Felker RE, et al. Diagnosis of early embryonic demise by endovaginal sonography. J Ultrasound Med 1990; 9:631.</a></li><li><a class="nounderline abstract_t">Pennell RG, Needleman L, Pajak T, et al. Prospective comparison of vaginal and abdominal sonography in normal early pregnancy. J Ultrasound Med 1991; 10:63.</a></li><li><a class="nounderline abstract_t">Flynn AN, Schreiber CA, Roe A, et al. Prioritizing Desiredness in Pregnancy of Unknown Location: An Algorithm for Patient-Centered Care. Obstet Gynecol 2020; 136:1001.</a></li><li><a class="nounderline abstract_t">McKenna KM, Feldstein VA, Goldstein RB, Filly RA. The empty amnion: a sign of early pregnancy failure. J Ultrasound Med 1995; 14:117.</a></li><li><a class="nounderline abstract_t">Yegul NT, Filly RA. The expanded amnion sign: evidence of early embryonic death. J Ultrasound Med 2009; 28:1331.</a></li><li><a class="nounderline abstract_t">Tan S, İpek A, Pektas MK, et al. Irregular yolk sac shape: is it really associated with an increased risk of spontaneous abortion? J Ultrasound Med 2011; 30:31.</a></li><li><a class="nounderline abstract_t">Tan S, Gülden Tangal N, Kanat-Pektas M, et al. Abnormal sonographic appearances of the yolk sac: which can be associated with adverse perinatal outcome? Med Ultrason 2014; 16:15.</a></li><li><a class="nounderline abstract_t">Naert MN, Khadraoui H, Muniz Rodriguez A, et al. Association Between First-Trimester Subchorionic Hematomas and Pregnancy Loss in Singleton Pregnancies. Obstet Gynecol 2019; 134:276.</a></li><li><a class="nounderline abstract_t">Tuuli MG, Norman SM, Odibo AO, et al. Perinatal outcomes in women with subchorionic hematoma: a systematic review and meta-analysis. Obstet Gynecol 2011; 117:1205.</a></li><li><a class="nounderline abstract_t">Baalmann CG, Galgano SJ, Pietryga JA, et al. A Case of a Chorionic Bump: New Sonographic-Histopathologic Findings With Review of the Literature. J Ultrasound Med 2017; 36:1968.</a></li><li><a class="nounderline abstract_t">Harris RD, Couto C, Karpovsky C, et al. The chorionic bump: a first-trimester pregnancy sonographic finding associated with a guarded prognosis. J Ultrasound Med 2006; 25:757.</a></li><li><a class="nounderline abstract_t">Yousaf A, Tayyab A, Anil MSU, et al. Chorionic Bump: Radiologic Features and Pregnancy Outcomes. Cureus 2020; 12:e11480.</a></li><li><a class="nounderline abstract_t">Vena F, Bartolone M, D'Ambrosio V, et al. Pregnancy and perinatal outcomes in pregnancy with diagnosis of chorionic bump on first-trimester sonography: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2022; 35:8897.</a></li><li><a class="nounderline abstract_t">Sepulveda W. Chorionic bump at 11 to 13 weeks' gestation: Prevalence and clinical significance. Prenat Diagn 2019; 39:471.</a></li></ol></div><div id="topicVersionRevision">Topic 130879 Version 9.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27875472" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Practice Bulletin No. 175: Ultrasound in Pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25044000" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : International standards for early fetal size and pregnancy dating based on ultrasound measurement of crown-rump length in the first trimester of pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30308091" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : AIUM-ACR-ACOG-SMFM-SRU Practice Parameter for the Performance of Standard Diagnostic Obstetric Ultrasound Examinations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30157093" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : ACOG Practice Bulletin No. 200: Early Pregnancy Loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24106937" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Diagnostic criteria for nonviable pregnancy early in the first trimester.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24106937" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Diagnostic criteria for nonviable pregnancy early in the first trimester.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24106937" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Diagnostic criteria for nonviable pregnancy early in the first trimester.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24106937" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Diagnostic criteria for nonviable pregnancy early in the first trimester.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33915095" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Sporadic miscarriage: evidence to provide effective care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21077156" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Clinical implications of intra- and interobserver reproducibility of transvaginal sonographic measurement of gestational sac and crown-rump length at 6-9 weeks' gestation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21997898" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Limitations of current definitions of miscarriage using mean gestational sac diameter and crown-rump length measurements: a multicenter observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2258994" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Diagnosis of early embryonic demise by endovaginal sonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2020050" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Prospective comparison of vaginal and abdominal sonography in normal early pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33030869" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Prioritizing Desiredness in Pregnancy of Unknown Location: An Algorithm for Patient-Centered Care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8568956" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The empty amnion: a sign of early pregnancy failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19778879" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The expanded amnion sign: evidence of early embryonic death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21193702" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Irregular yolk sac shape: is it really associated with an increased risk of spontaneous abortion?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24567919" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Abnormal sonographic appearances of the yolk sac: which can be associated with adverse perinatal outcome?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31306310" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Association Between First-Trimester Subchorionic Hematomas and Pregnancy Loss in Singleton Pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21508763" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Perinatal outcomes in women with subchorionic hematoma: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28503780" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : A Case of a Chorionic Bump: New Sonographic-Histopathologic Findings With Review of the Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16731892" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The chorionic bump: a first-trimester pregnancy sonographic finding associated with a guarded prognosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33329976" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Chorionic Bump: Radiologic Features and Pregnancy Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34809513" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Pregnancy and perinatal outcomes in pregnancy with diagnosis of chorionic bump on first-trimester sonography: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30916793" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Chorionic bump at 11 to 13 weeks' gestation: Prevalence and clinical significance.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
